Twist Bioscience (TWST) Net Cash Flow Growth (1y) (2018 - 2026)
Twist Bioscience (TWST) Net Cash Flow Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 498.33% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -260.86% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 73.93% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 722.22% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -115.29% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -58.16% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 73.12% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | -441.96% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 84.25% |
| 10 | Twist Bioscience | 7.18 Bn | 7.02 Bn | 62.45 Mn | 40.97% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 40.97% |
| Mar 31, 2026 | -132.94% |
| Dec 31, 2025 | -586.24% |
| Sep 30, 2025 | -43.65% |
| Jun 30, 2025 | -114.57% |
| Mar 31, 2025 | 50.88% |
| Dec 31, 2024 | 75.25% |
| Sep 30, 2024 | 42.34% |
| Jun 30, 2024 | 22.62% |
| Mar 31, 2024 | -1,324.52% |
| Dec 31, 2023 | 66.99% |
| Sep 30, 2023 | -916.73% |
| Jun 30, 2023 | 82.72% |
| Mar 31, 2023 | -100.74% |
| Dec 31, 2022 | 77.60% |
| Sep 30, 2022 | 129.58% |
| Jun 30, 2022 | -141.23% |
| Mar 31, 2022 | 327.75% |
| Dec 31, 2021 | -207.10% |
| Sep 30, 2021 | 91.85% |